Frontotemporal Dementia (FTD) is the most common form of dementia for those under 60. Under-diagnosed and currently incurable, FTD can be caused by a mutated gene, including the MAPT gene. Cure MAPT FTD raises awareness of the MAPT genetic mutation causing FTD, assists a global network of MAPT families, and advocates for trials that will lead to a cure.
Contact Us
The MAPT gene encodes “microtubule-associated protein tau” which is expressed within the neurons in the brain. Mutations in the MAPT gene can exert several different effects on how this process functions. These differences in function can be unique to each specific mutation, but all result in the formation of aggregated tau inclusions, also known as tangles, which are theorized to drive neuronal loss and brain atrophy.
Learn More
Spread awareness of FTD, of the importance of genetic testing, and of Tau/MAPT.
Advocate for MAPT-specific trials and access to other FTD gene-specific trials.
Find, and connect to, the growing global network of MAPT families and researchers.
Linde Jacobs was featured in a New York Times article by author Virginia Hughes, articulating Linde's experience growing up with this generational disease, discovering her genetic status, and advocating fiercely for a cure.
Read the full story
In 2023, one of the founding families of Cure MAPT FTD was featured inarticle by award-winning journalist and New York Times-bestselling author, Robert Kolker.
Read the full storyListen to the NYT podcastDecember 5, 2025
EST
Upcoming
You won’t want to miss our final Friday Family Meeting of the year! In addition to our usual community updates and the opportunity to connect with fellow MAPT families, we’re thrilled to welcome a very special guest: Dr. Sally Temple. Dr. Temple is a valued member of our Scientific Advisory Board and the Scientific Director at the Neural Stem Cell Institute. She’ll be sharing insights into her groundbreaking work using organoid models and a recently awarded NINDS grant focused on developing MAPT-specific models. This work represents an important step forward in understanding and ultimately treating MAPT-related FTD. Come join us to hear directly from Dr. Temple, ask questions, and learn how her research is helping move us closer to answers.
.jpg)
Are you interested in genetic testing? MAPT trials? Support and resources for FTD? Contact us and we'll get back to you quickly.
hello@curemaptftd.org.png)
Stay in touch:
.svg.png){kind=icon}